Australia's largest stock trading and investment forum Australia's #1 stock forum

LDX

0.00%

4.5¢ lumos diagnostics holdings limited

Ann: Lumos Receives US FDA Clearance for FebriDx, page-226

First 226 Last

Share
Profile

Follow
MrFantasticMan

978 Posts.

101

04/07/23

16:04

Post #: 68615168
Share

Originally posted by agj26: ↑

Not true - 'traditional swab tests take days to get a result'.

I'm not a medical professional but live in PNG. Many will appreciate the standard of medical care here is not even close to what we have in Australia.

I have had a bad run with flu and infections this year. I went to a doctor recently and was asked to provide a sputum sample for a lab test to determine if my respiratory tract / chest infection was bacterial or viral.

5-10 minutes later, test confirmed it was bacterial. Antibiotics.

I had no idea such a test existed, or that it could be done so quickly. It was certainly not Lumos' test. So there are ways and means already.

For Lumos to succeed with its FebriDx test, clinicians and GP's need to adapt to new work practices. It may not be so easy.

I'm a former shareholder in Lumos, exited last year before the worst of the crash. Big congrats to the long-term shareholders that stayed the course and took advantage of the SP at its lows. @LongTony and others. Well done.

The cash burn is still around $1m per month, so unless a deal is forthcoming with upfront cash, Lumos will need to raise cash soon. But under very different circumstances to their last raise - from a position of strength.

Good luck.

Expand

Jesus Christ, mate.

And there are treatments and practices common in PNG that are banned in the USA.

LDX Price at posting: 15.5¢ Sentiment: None Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

What's causing the cost-of-living crisis, and how to navigate it

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint